VanEck Associates
MEDP icon

VanEck Associates’s Medpace MEDP Stock Holding History

VanEck Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
24,835
+76
+0.3% +$35.1K 0.01% 550
2026
Q1 		$11.9M Buy
24,759
+1,019
+4% +$522K 0.01% 544
2025
Q4 		$13.3M Sell
23,740
-2,303
-9% -$1.31M 0.01% 485
2025
Q3 		$13.4M Buy
26,043
+466
+2% +$203K 0.01% 454
2025
Q2 		$8.03M Sell
25,577
-4,623
-15% -$1.39M 0.01% 554
2025
Q1 		$9.2M Buy
30,200
+2,940
+11% +$989K 0.01% 506
2024
Q4 		$9.06M Buy
27,260
+7,027
+35% +$2.38M 0.01% 496
2024
Q3 		$6.68M Buy
20,233
+5,781
+40% +$2.2M 0.01% 559
2024
Q2 		$5.95M Buy
14,452
+3,251
+29% +$1.29M 0.01% 530
2024
Q1 		$4.53M Buy
11,201
+2,996
+37% +$1.05M 0.01% 618
2023
Q4 		$2.52M Buy
8,205
+2,258
+38% +$610K ﹤0.01% 743
2023
Q3 		$1.44M Buy
5,947
+1,783
+43% +$456K ﹤0.01% 805
2023
Q2 		$1M Buy
4,164
+182
+5% +$37.8K ﹤0.01% 867
2023
Q1 		$749K Buy
3,982
+2,943
+283% +$609K ﹤0.01% 901
2022
Q4 		$221K Buy
1,039
+172
+20% +$34.4K ﹤0.01% 1069
2022
Q3 		$136K Buy
867
+78
+10% +$12.4K ﹤0.01% 1120
2022
Q2 		$118K Buy
789
+17
+2% +$2.46K ﹤0.01% 1194
2022
Q1 		$126K Buy
772
+106
+16% +$17.5K ﹤0.01% 1195
2021
Q4 		$145K Buy
666
+58
+10% +$12.1K ﹤0.01% 1173
2021
Q3 		$115K Buy
608
+226
+59% +$41.2K ﹤0.01% 1126
2021
Q2 		$67K Buy
+382
New +$65.9K ﹤0.01% 1164

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VanEck Associates's MEDP Position: Q2 2026 in Review

VanEck Associates increased its Medpace (MEDP) stake by 0.31% in Q2 2026, buying an estimated $35.1K and bringing the position to 24,835 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #550.

VanEck Associates first reported a position in MEDP in Q2 2021 and has held it in 21 quarters since. The position peaked at $13.4M in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • VanEck Associates held 24,835 shares of Medpace worth $13.2M as of Q2 2026.
  • VanEck Associates bought 76 Medpace shares in Q2 2026, an estimated $35.1K.
  • Medpace made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #550 holding.
  • VanEck Associates first reported a position in Medpace in Q2 2021 and has held it in 21 quarters since.
  • VanEck Associates's Medpace position peaked at $13.4M in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.